Aphios

Biopharmaceutical company developing enabling technology platforms and enhanced natural therapeutics for certain infectious diseases, cancers and CNS disorders

Enhanced therapeutics include small molecules from medicinal plants and marine organisms, and improved drug delivery formulations of protein macromolecules and hydrophobic anticancer drugs

Enabling technology platforms, nanotechnologies and therapeutic products covered by 33 issued U.S. and international patents, and 27 pending patent applications

History of collaborations with multinational companies such as Novartis, Bayer, Bristol-Myers Squibb, Eli Lilly and the Gillette Company, and leading academic institutions.